Sales Growth YoY (Last 12 Months): lavatherapeutics.com (LVTX)

Public company logo of lavatherapeutics.com (LVTX)

The rolling annual change in sales volume, combined with adherence to temperature-controlled drug delivery protocols, ensures supply stability for LAVA Therapeutics N.V. (LVTX). The current value of -31.90 determines the status of the revenue dynamics parameter. Environmental sustainability is confirmed by the implementation of "green chemistry" within the laboratories. However, the preclinical status of the drugs and reliance on partner payments limit business scaling amid rising costs.

Lava Tx (LVTX) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 12/06/2025

LAVA Therapeutics N.V. (LVTX) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:LAVA Therapeutics N.V.
Product sample of Lava Tx

LAVA Therapeutics N.V. (LVTX) is developing innovative bispecific antibodies, seeking strategic partnerships with pharmaceutical behemoths. By analyzing the year-over-year product realization dynamics for the TTM on GURU.Markets, one can assess the pace of revenue expansion. This indicator measures the rolling annual revenue growth, identifying early signs of business stagnation or acceleration. For LAVA Therapeutics N.V. (LVTX), this serves as a marker of commercialization efficiency outside of price wars. Stable growth confirms the company's fundamental resilience.

Competitors of LAVA Therapeutics N.V. (LVTX)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Sutro Biopharma Inc.|Sales Growth YoY (Last Twelve Months) MiNK Therapeutics (INKT)|HOWL: Trailing Twelve Months Sales Growth|Immix Biopharma - Revenue Growth YoY (Last 12 Months)|ALX Oncology (ALXO) - Trailing Twelve Months Revenue Growth|CUE: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth PDSB|sonnetbio.com (SONN) - Sales Growth YoY (Last Twelve Months)|MAIA Biotechnology Inc (MAIA) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) liminatuspharma.com|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)